These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10700602)

  • 1. Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry.
    Kalia M; O'Callaghan JP; Miller DB; Kramer M
    Brain Res; 2000 Mar; 858(1):92-105. PubMed ID: 10700602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine.
    Cheetham SC; Viggers JA; Slater NA; Heal DJ
    Neuropharmacology; 2000 Aug; 39(11):2028-35. PubMed ID: 10963746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.
    Wellman PJ; Jones SL; Miller DK
    Pharmacol Biochem Behav; 2003 Apr; 75(1):103-14. PubMed ID: 12759118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs.
    Gardier AM; Kaakkola S; Erfurth A; Wurtman RJ
    Brain Res; 1992 Aug; 588(1):67-74. PubMed ID: 1382807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexfenfluramine and norfenfluramine: comparison of mechanism of action in feeding and brain Fos-ir studies.
    Rowland NE; Roth JD; McMullen MR; Patel A; Cespedes AT
    Am J Physiol Regul Integr Comp Physiol; 2000 Feb; 278(2):R390-9. PubMed ID: 10666140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.
    Thomas GH; Babbs AJ; Chatfield RE; Krülle TM; Widdowson PS; Provost D; McCormack JG
    Obesity (Silver Spring); 2009 Mar; 17(3):467-73. PubMed ID: 19219064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion.
    Andó RD; Adori C; Kirilly E; Molnár E; Kovács GG; Ferrington L; Kelly PA; Bagdy G
    Behav Brain Res; 2010 Mar; 207(2):280-9. PubMed ID: 19840819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+/-)-MDMA neurotoxicity: protection by fluoxetine.
    Virden TB; Baker LE
    Behav Pharmacol; 1999 Mar; 10(2):195-204. PubMed ID: 10780832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anorectic effect of dehydroepiandrosterone combined with dexfenfluramine or thionisoxetine.
    Rowland NE; Marshall M; Robertson K
    Eur J Pharmacol; 2001 May; 419(1):61-4. PubMed ID: 11348631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET.
    Li IH; Huang WS; Shiue CY; Huang YY; Liu RS; Chyueh SC; Hu SH; Liao MH; Shen LH; Liu JC; Ma KH
    Neuroimage; 2010 Jan; 49(2):1259-70. PubMed ID: 19682588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
    O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
    Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
    Fletcher PJ; Sinyard J; Salsali M; Baker GB
    Psychopharmacology (Berl); 2004 Jul; 174(3):406-13. PubMed ID: 14740149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
    Durkin S; Prendergast A; Harkin A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
    Gudelsky GA; Nash JF
    J Neurochem; 1996 Jan; 66(1):243-9. PubMed ID: 8522960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the repeated administration of the compound 3,4-methylenedioxymethamphetamine on the response of rats to the 5-HT2A,C receptor agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Granoff MI; Ashby CR
    Neuropsychobiology; 1998; 37(1):36-40. PubMed ID: 9438270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
    Garattini S; Bizzi A; Caccia S; Mennini T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion.
    Aguirre N; Ballaz S; Lasheras B; Del Río J
    Eur J Pharmacol; 1998 Apr; 346(2-3):181-8. PubMed ID: 9652358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats.
    Rowland NE; Marshall M; Roth JD
    Psychopharmacology (Berl); 2000 Mar; 149(1):77-83. PubMed ID: 10789886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.